Ameriprise
TTOO

Ameriprise’s T2 Biosystems, Inc TTOO Stock Holding History

Ameriprise’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed -$10K – 4012
2022
Q1 		$10K Sell
4
-1
-20% -$2.12K ﹤0.01% 3914
2021
Q4 		$13K Sell
5
-32
-86% -$111K ﹤0.01% 3934
2021
Q3 		$171K Sell
37
-4
-10% -$20.1K ﹤0.01% 3728
2021
Q2 		$244K Sell
41
-2
-5% -$12.9K ﹤0.01% 3705
2021
Q1 		$348K Sell
43
-16
-27% -$169K ﹤0.01% 3542
2020
Q4 		$365K Sell
59
-9
-13% -$55.1K ﹤0.01% 3443
2020
Q3 		$465K Buy
68
+34
+100% +$252K ﹤0.01% 3264
2020
Q2 		$216K Buy
+34
New +$144K ﹤0.01% 3470

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ameriprise's TTOO Position: Q2 2022 in Review

Ameriprise sold out of T2 Biosystems, Inc (TTOO) in Q2 2022, closing a stake of 4 shares — an estimated $10K sold.

Ameriprise first reported a position in TTOO in Q2 2020 and held it in 8 quarters. The position peaked at $465K in Q3 2020. 58 funds tracked by Wall St. Rank hold TTOO as of Q2 2022.

  • Ameriprise reported no remaining T2 Biosystems, Inc position as of Q2 2022 after selling out during the quarter.
  • Ameriprise sold 4 T2 Biosystems, Inc shares in Q2 2022, an estimated $10K.
  • Ameriprise first reported a position in T2 Biosystems, Inc in Q2 2020 and held it in 8 quarters.
  • Ameriprise's T2 Biosystems, Inc position peaked at $465K in Q3 2020.
  • 58 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2022.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.